Literature DB >> 26253453

Ischemic postconditioning altered microRNAs in human valve replacement.

Yang Gao1, Rimao Huang1, Ri Chen1, Jun Li1, Wanjun Luo2.   

Abstract

BACKGROUND: Although the involvement of microRNAs (miRNAs) has been intensively studied in myocardial infarction, there is no report on the regulation of miRNAs by ischemic postconditioning in patients undergoing cardiac surgery. We aim to explore the regulation of miRNAs by ischemic postconditioning in double valve replacement.
MATERIALS AND METHODS: In this prospective, controlled clinical study, consecutive 30 patients undergoing double valve replacement were enrolled. The patients were randomized into two groups, namely an ischemic postconditioning (IPO) group (n = 15) and a control (CON) group (n = 15). For ethical considerations, samples of right atrial muscle were harvested, respectively, 10 min before cardiopulmonary bypass (pre-CPB) and 5 min after aortic declamping (post-CPB) for analysis of miRNAs, genes and apoptosis.
RESULTS: Compared with the CON group, miR-1 was downregulated, whereas miR-21 was upregulated, and BCL2 messenger RNA (mRNA) was upregulated, whereas BAX mRNA and programmed cell death 4 mRNA remained unchanged in the IPO group. Likewise, a significant increase in BCL2 protein and a striking decrease in BAX protein were observed in the IPO group when compared with those in the CON group. The IPO group showed a significantly smaller increase of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive myocytes after CPB than CON group.
CONCLUSIONS: Ischemic postconditioning could regulate miR-1, miR-21, and downstream effectors and resulted in actual attenuation of apoptosis in patients undergoing valvular heart surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; MicroRNAs; Postconditioning; Valve replacement

Mesh:

Substances:

Year:  2015        PMID: 26253453     DOI: 10.1016/j.jss.2015.07.010

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Knockdown of miR-1275 protects against cardiomyocytes injury through promoting neuromedin U type 1 receptor.

Authors:  Zhu Zeng; Haixin Ma; Jing Chen; Nina Huang; Yudan Zhang; Yufei Su; Huifang Zhang
Journal:  Cell Cycle       Date:  2020-12-15       Impact factor: 4.534

2.  Ischemic Postconditioning Protects Against Intestinal Ischemia/Reperfusion Injury via the HIF-1α/miR-21 Axis.

Authors:  Zhongzhi Jia; Weishuai Lian; Haifeng Shi; Chuanwu Cao; Shilong Han; Kai Wang; Maoquan Li; Xiaoping Zhang
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 3.  Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic Options.

Authors:  Gangling Chen; Mrugesh Thakkar; Christopher Robinson; Sylvain Doré
Journal:  Front Neurol       Date:  2018-02-06       Impact factor: 4.003

Review 4.  miR-21 in Human Cardiomyopathies.

Authors:  Surina Surina; Rosaria Anna Fontanella; Lucia Scisciola; Raffaele Marfella; Giuseppe Paolisso; Michelangela Barbieri
Journal:  Front Cardiovasc Med       Date:  2021-10-27

5.  Ischemic postconditioning protects nonculprit coronary arteries against ischemia-reperfusion injury via downregulating miR-92a, miR-328 and miR-494.

Authors:  Jian Wang; Wu Wang; Chengying Yan; Tianzhen Wang
Journal:  Aging (Albany NY)       Date:  2022-03-23       Impact factor: 5.682

Review 6.  Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection.

Authors:  Branislav Kura; Barbora Kalocayova; Yvan Devaux; Monika Bartekova
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.